medroxyprogesterone acetate has been researched along with Insulin Resistance in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (13.64) | 18.2507 |
| 2000's | 15 (68.18) | 29.6817 |
| 2010's | 4 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bahamondes, L; Cursino, K; dos Santos, Pde N; Fernandes, A; Pavin, EJ; Sider, M; Zantut-Wittmann, DE | 1 |
| Hanaoka, H; Kiyokawa, T; Koshizaka, M; Mitsuhashi, A; Sato, Y; Shozu, M | 1 |
| Baskan, B; Demir, B; Haberal, A; Kandemir, O; Karabulut, E; Ozturkoglu, E; Solaroglu, A | 1 |
| Bagis, T; Haydardedeoglu, B; Kilicdag, EB; Simsek, E | 1 |
| Blackman, MR; Harman, SM; Münzer, T; Sorkin, JD | 1 |
| Buchanan, TA; Jurow, R; Liu, X; Segall-Gutierrez, P; Stanczyk, FZ; Trigo, E; Watanabe, RM; Xiang, AH | 1 |
| Baum, ST; Colman, RJ; Cruzen, CL | 1 |
| Bagis, T; Gokcel, A; Haydardedeoglu, B; Kilicdag, EB; Tarim, E; Zeyneloglu, HB | 1 |
| Akinci, SB; Gulec, M; Polat, Z; Saglam, K; Yilmaz, MI | 1 |
| Anthony, MS; Clarkson, TB; Rankin, SE; Shadoan, MK; Wagner, JD | 1 |
| Alderman, EL; Howard, BV; Hsia, J; Lindsay, J; Ouyang, P; Silverman, A; Tripputi, M; Van Voorhees, L; Waters, DD | 1 |
| Allen, C; Bassford, T; Bonds, DE; Burke, G; Howard, BV; Margolis, KL; Phillips, LS; Rodabough, RJ; Tinker, L; Torrens, J | 1 |
| Abbà, C; Ambroggio, S; Campagnoli, C; Peris, C | 1 |
| Brochu, M; Cooper, BC; Fairhurst, PA; L'Hommedieu, GD; Sites, CK; Toth, MJ | 1 |
| Abdelnoor, M; Birkeland, K; Larsen, A; Os, A; Os, I; Westheim, A | 1 |
| Botsis, D; Caramalis, G; Christodoulakos, G; Creatsas, G; Lambrinoudaki, I; Panoulis, C; Rizos, D; Sioulas, V | 1 |
| Gannon, B; Goodrow, GJ; L'Hommedieu, GD; Sites, CK | 1 |
| Burger, NZ; Cooper, BC; Cushman, M; Sites, CK; Toth, MJ | 1 |
| Anthony, MS; Kavanagh, K; Shadoan, MK; Wagner, JD; Zhang, L | 1 |
| Duffy, DM; Kojima, T; Lindheim, SR; Lobo, RA; Stanczyk, FZ; Vijod, MA | 1 |
| Azziz, R | 1 |
| Clarkson, TB | 1 |
1 review(s) available for medroxyprogesterone acetate and Insulin Resistance
| Article | Year |
|---|---|
Progestogens and cardiovascular disease. A critical review.
Topics: Cardiovascular Diseases; Coronary Artery Disease; Disease Progression; Estrogens; Female; Hormone Replacement Therapy; Humans; Hyperglycemia; Insulin Resistance; Lipoproteins, LDL; Medroxyprogesterone Acetate; Progesterone Congeners; Progestins | 1999 |
13 trial(s) available for medroxyprogesterone acetate and Insulin Resistance
| Article | Year |
|---|---|
Phase II study of medroxyprogesterone acetate plus metformin as a fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer.
Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Female; Fertility; Fertility Preservation; Humans; Insulin Resistance; Medroxyprogesterone Acetate; Metformin; Neoplasm Recurrence, Local; Prospective Studies; Treatment Outcome; Young Adult | 2016 |
The effects of estrogen therapy and estrogen combined with different androgenic progestins on carbohydrate and lipid metabolism in overweight-obese younger postmenopausal women.
Topics: Blood Glucose; Carbohydrate Metabolism; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Humans; Insulin Resistance; Lipid Metabolism; Medroxyprogesterone Acetate; Nandrolone; Norethindrone; Norethindrone Acetate; Obesity; Progesterone Congeners; Prospective Studies | 2008 |
Metabolic and endocrine effects of metformin and metformin plus cyclic medroxyprogesterone acetate in women with polycystic ovary syndrome.
Topics: Adolescent; Adult; Body Mass Index; Cholesterol; Contraceptive Agents, Female; Drug Therapy, Combination; Female; Follow-Up Studies; Homeostasis; Homocysteine; Humans; Hypoglycemic Agents; Insulin Resistance; Medroxyprogesterone Acetate; Metformin; Polycystic Ovary Syndrome; Prospective Studies; Young Adult | 2009 |
Growth hormone and sex steroid effects on serum glucose, insulin, and lipid concentrations in healthy older women and men.
Topics: Administration, Cutaneous; Administration, Oral; Aged; Aged, 80 and over; Blood Glucose; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Female; Gonadal Steroid Hormones; Human Growth Hormone; Humans; Insulin; Insulin Resistance; Lipids; Male; Medroxyprogesterone Acetate; Reference Values; Testosterone | 2009 |
Deterioration in cardiometabolic risk markers in obese women during depot medroxyprogesterone acetate use.
Topics: Adult; Biomarkers; Cardiovascular Diseases; Contraceptive Agents, Female; Female; Humans; Insulin Resistance; Medroxyprogesterone Acetate; Obesity; Pregnancy; Prospective Studies; Risk Factors; Young Adult | 2012 |
The effects of short-term medroxyprogesterone acetate and micronized progesterone on glucose metabolism and lipid profiles in patients with polycystic ovary syndrome: a prospective randomized study.
Topics: Administration, Intravaginal; Administration, Oral; Adult; Blood Glucose; Body Mass Index; Cholesterol, LDL; Female; Homeostasis; Humans; Insulin; Insulin Resistance; Lipids; Lipoprotein(a); Luteinizing Hormone; Medroxyprogesterone Acetate; Polycystic Ovary Syndrome; Progesterone; Prospective Studies; Testosterone | 2002 |
Postmenopausal hormone therapy is associated with atherosclerosis progression in women with abnormal glucose tolerance.
Topics: Adult; Aged; Blood Glucose; C-Reactive Protein; Canada; Comorbidity; Coronary Angiography; Coronary Artery Disease; Diabetes Mellitus; Disease Progression; Drug Combinations; Estrogens, Conjugated (USP); Female; Fibrinogen; Follow-Up Studies; Glucose Intolerance; Hormone Replacement Therapy; Humans; Hysterectomy; Inflammation; Insulin; Insulin Resistance; Lipoproteins, HDL; Medroxyprogesterone Acetate; Middle Aged; Obesity; Postmenopause; Prospective Studies; Single-Blind Method; Triglycerides; United States | 2004 |
Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women's Health Initiative Hormone Trial.
Topics: Aged; Alcohol Drinking; Body Mass Index; Body Size; Diabetes Mellitus; Double-Blind Method; Energy Intake; Estrogens, Conjugated (USP); Female; Humans; Incidence; Insulin Resistance; Medroxyprogesterone Acetate; Middle Aged; Patient Selection; Smoking | 2004 |
The effect of hormone replacement therapy on body composition, body fat distribution, and insulin sensitivity in menopausal women: a randomized, double-blind, placebo-controlled trial.
Topics: Adipose Tissue; Blood Glucose; Body Composition; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Insulin; Insulin Resistance; Medroxyprogesterone Acetate; Menopause; Middle Aged | 2005 |
Insulin sensitivity in women with coronary heart disease during hormone replacement therapy.
Topics: Aged; Coronary Disease; Dose-Response Relationship, Drug; Estradiol; Estrogen Replacement Therapy; Female; Humans; Insulin; Insulin Resistance; Insulin Secretion; Medroxyprogesterone Acetate; Middle Aged; Norway; Postmenopause; Time Factors; Women's Health | 2005 |
Predictors of worsening insulin sensitivity in postmenopausal women.
Topics: Absorptiometry, Photon; Adipose Tissue; Aged; Blood Glucose; Body Composition; Body Mass Index; Diabetes Mellitus; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Glucose Clamp Technique; Humans; Insulin; Insulin Resistance; Logistic Models; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Risk Factors; Time Factors | 2006 |
Insulin resistance with hormone replacement therapy: associations with markers of inflammation and adiposity.
Topics: Adiponectin; Adiposity; Biomarkers; Body Composition; C-Reactive Protein; Double-Blind Method; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Insulin Resistance; Interleukin-6; Leptin; Medroxyprogesterone Acetate; Middle Aged | 2007 |
The route of administration influences the effect of estrogen on insulin sensitivity in postmenopausal women.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Blood Glucose; Drug Combinations; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Insulin; Insulin Resistance; Medroxyprogesterone Acetate; Middle Aged; Postmenopause | 1994 |
8 other study(ies) available for medroxyprogesterone acetate and Insulin Resistance
| Article | Year |
|---|---|
Insulin resistance parameters in users of the injectable contraceptive depot medroxyprogesterone acetate during one year of use.
Topics: Adiposity; Adult; Body Composition; Body Mass Index; Contraceptive Agents, Female; Female; Follow-Up Studies; Humans; Insulin Resistance; Intrauterine Devices, Medicated; Medroxyprogesterone Acetate; Prospective Studies; Risk Factors; Weight Gain; Young Adult | 2016 |
Glucoregulatory function in adult rhesus macaques (Macaca mulatta) undergoing treatment with medroxyprogesterone acetate for endometriosis.
Topics: Animals; Animals, Laboratory; Blood Glucose; Cross-Sectional Studies; Endometriosis; Female; Insulin Resistance; Longitudinal Studies; Macaca mulatta; Medroxyprogesterone Acetate; Monkey Diseases; Time Factors | 2011 |
Effects of postmenopausal hormone replacement therapy on insulin resistance.
Topics: C-Peptide; Cholesterol, HDL; Cholesterol, LDL; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Glucose Clamp Technique; Humans; Insulin; Insulin Resistance; Medroxyprogesterone Acetate; Middle Aged; Reference Values; Triglycerides | 2002 |
Effects of tibolone and conjugated equine estrogens with or without medroxyprogesterone acetate on body composition and fasting carbohydrate measures in surgically postmenopausal monkeys.
Topics: Animals; Arteriosclerosis; Blood Glucose; Body Composition; Body Weight; C-Peptide; Carbohydrates; Dietary Fats; Energy Intake; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Fasting; Female; Fructosamine; Insulin; Insulin Resistance; Macaca fascicularis; Medroxyprogesterone Acetate; Norpregnenes; Ovariectomy; Postmenopause | 2003 |
Effects of estrogen-only treatment in postmenopausal women.
Topics: Breast Neoplasms; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Insulin Resistance; Insulin-Like Growth Factor I; Medroxyprogesterone Acetate; Middle Aged; Neoplasms, Hormone-Dependent; Postmenopause | 2004 |
Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene.
Topics: Adult; Aged; Androgens; Cross-Sectional Studies; Dehydroepiandrosterone Sulfate; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Insulin; Insulin Resistance; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Sex Hormone-Binding Globulin; Testosterone | 2005 |
Addition of medroxyprogesterone acetate to conjugated equine estrogens results in insulin resistance in adipose tissue.
Topics: Adipocytes; Adipose Tissue; Animals; Body Composition; Body Weight; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Insulin Resistance; Macaca fascicularis; Medroxyprogesterone Acetate | 2007 |
The hyperandrogenic-insulin-resistant acanthosis nigricans syndrome: therapeutic response.
Topics: Acanthosis Nigricans; Adolescent; Contraceptives, Oral; Drug Therapy, Combination; Female; Humans; Hyperandrogenism; Insulin Resistance; Leuprolide; Medroxyprogesterone Acetate; Spironolactone | 1994 |